| |
| |
|
| Insider
Information: |
Kolterman Orville G |
| Relationship: |
SVP, Chief Medical Off... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
SVP, Chief Medical Off... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$642,993 |
I/I |
(20,742) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$5,969,388 |
D/D |
(192,561) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$2,211,819 |
D/D |
(71,349) |
192,561 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-08-08 |
4 |
A |
$31.00 |
$2,211,819 |
D/D |
71,349 |
263,910 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-07-26 |
4 |
OE |
$11.95 |
$242,585 |
D/D |
20,300 |
197,135 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-07-26 |
4 |
D |
$30.80 |
$412,407 |
D/D |
(13,392) |
192,561 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-07-25 |
4 |
A |
$14.62 |
$20,117 |
D/D |
1,376 |
185,653 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,529 |
7,974 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
184,277 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-03-01 |
4 |
S |
$17.11 |
$31,585 |
D/D |
(1,846) |
174,277 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2012-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
171,457 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2012-02-08 |
4 |
S |
$16.62 |
$93,661 |
D/D |
(5,637) |
165,820 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,630 |
6,445 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2011-03-01 |
4 |
AS |
$15.02 |
$206,512 |
D/D |
(13,750) |
155,136 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2011-03-01 |
4 |
OE |
$5.73 |
$139,481 |
D/D |
13,750 |
161,386 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
155,136 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2011-02-01 |
4 |
AS |
$16.16 |
$40,409 |
D/D |
(2,500) |
151,639 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2011-02-01 |
4 |
OE |
$11.13 |
$27,813 |
D/D |
2,500 |
154,139 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2011-01-18 |
4 |
AS |
$15.00 |
$37,500 |
D/D |
(2,500) |
151,639 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2011-01-18 |
4 |
OE |
$11.13 |
$27,813 |
D/D |
2,500 |
154,139 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP Research & Development |
• – – |
2010-02-03 |
4 |
A |
$17.83 |
$7,346 |
D/D |
412 |
144,839 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP Research & Development |
• – – |
2010-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,360 |
4,815 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2009-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
2,550 |
3,455 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2009-02-26 |
4 |
OE |
$0.78 |
$12,765 |
D/D |
16,344 |
143,265 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2009-02-03 |
4 |
A |
$11.80 |
$6,903 |
D/D |
585 |
126,921 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
